Low Dose Naltrexone (LDN), a breakthrough treatment for chronic and autoimmune diseases, is helping over 300,000 patients worldwide. LDNscience, by MedInsight, is the most authoritative and up-to date source of information about LDN, housing the entire collection of research and scientific studies, interviews with scientists, physicians and patients, a free global LDN prescriber directory, and frequently asked questions.
Cureiosity® is a repository of manually curated knowledge about novel treatments for serious, chronic, and intractable diseases. The knowledge is created by data-scientists who analyze the global medical literature, and catalogue the information they extract in a proprietary manner using a next-generation graph-database. Cureiosity places patients’ interest first by focusing on overlooked treatments that don’t benefit from commercial sponsorship.